Navigation Links
Research Demonstrates Impact of 2’-Fucosyllactose (2’FL) on Gut Microbiota and Metabolite Production
Date:10/8/2019

Continuing its leading research on human milk oligosaccharides (HMOs), DuPont released the findings of a new study showing that Care4U™ 2’-FL, a DuPont product, beneficially changes microbiota composition and the production of microbial metabolites in comparison to galacto-oligosaccharides (GOS) and lactose. The effects elicited to microbiota and metabolite composition by 2’-FL were between the responses elicited by GOS and lactose, which indicates that 2’-FL is selectively fermented by the infant microbes.

“Our previous in vitro cultivation experiments, as well as literature, indicated that 2’-FL is selectively utilized by only certain types of bifidobacteria and Bacteroides species, and this type of modelling with a complex microbiota is a step ahead in our journey to understand the prebiotic mechanisms of 2’-FL,” indicated Krista Salli, M.Sc., Scientist, DuPont Nutrition & Biosciences.

“This study exemplifies the utility of the DuPont™ Enteromix® infant gut simulator to compare the fermentation of the carbohydrates between each other,” said Heli Anglenius, Ph.D., Senior Scientist, DuPont Nutrition & Biosciences. “Over the years, the Enteromix® gut simulator developed in-house in Kantvik, Finland, has been used successfully for a multitude of studies with fecal microbiota sampled from adults, and this study demonstrates its applicability to studies where the microbiota is obtained from infants. This is a great continuation for more than 20 years of expertise using our own pre-clinical modelling.”

Among the study’s other achievements was the comparison of 2’-FL to GOS and lactose.

“While this study was done under simulated gut conditions, it showed the differences between the carbohydrates, especially in the production of microbial metabolites,” said Ratna Mukherjea, Ph.D., Technical Fellow and Global Research and Development Leader-Human Milk Oligosaccharides (HMO), DuPont Nutrition & Biosciences. “These kind of study approaches can give more understanding on the how HMOs can be utilized by the microbiota with a method that is not invasive, which is important especially in the case of infants.”

You can read more about this study at https://www.nature.com/articles/s41598-019-49497-z.

About DuPont™ Danisco®

DuPont™ Danisco® is the brand for a range of products that help provide enhanced bioprotection, an improved nutritional profile, and better taste and texture with greater cost efficiency and lower environmental impact, meeting the needs of manufacturers of food and beverages and dietary supplements. Through the work of the global network of food scientists and technologists in DuPont, the Danisco® range is supported by a uniquely broad spectrum of know-how across applications and processing.

About DuPont Nutrition & Biosciences

DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. We are innovative solvers who help our customers turn challenges into high-value business opportunities. For more information: http://www.dupontnutritionandbiosciences.com or http://www.biosciences.dupont.com.

About DuPont

DuPont (NYSE: DD) is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, health and wellness, food, and worker safety. More information can be found at http://www.dupont.com.

# # #

10/08/19

DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.

Read the full story at https://www.prweb.com/releases/research_demonstrates_impact_of_2_fucosyllactose_2fl_on_gut_microbiota_and_metabolite_production/prweb16630005.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine news :

1. Cerebral Palsy Alliance Research Foundation Joins World CP Day On October 6, 2019
2. Distinguished Speakers to Share Latest Research and Key Findings at LabRoots' 7th Annual Cancer Research & Oncology Virtual Event
3. Institute for Mental Health Research Appoints Mitzi Krockover as Board Chair
4. Pink Garments Bring Awareness to Pink Pride Month. Hallak Cleaners supports breast cancer awareness and research with their annual version of Pink Pride month.
5. MRF & MRA Commend the Senate Appropriations Committee for Supporting $20 Million for Defense-Funded Melanoma Research
6. RBMA Establishes Foundation for Education and Research
7. Six Consulting Announces Selection of Corporate Social Responsibility (CSR) Initiatives: Promoting STEM Education and Cancer Research in Canines
8. Announcing The Gift of Participation, 3rd edition, the Ultimate Guidebook on Clinical Research Participation
9. World Molecular Imaging Society Highlights First-in-Human Infectious Disease Research in the Quest for Detection and Treatment
10. Black Book Market Research Ranks iPatientCare Once Again Among Top Specialty-Specific EHR Vendors for 2019
11. Window World Donates $500K to St. Jude Children’s Research Hospital in Honor of Childhood Cancer Awareness Month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2020)... ... 31, 2020 , ... Cardiothoracic surgeons at Allegheny General Hospital ... Mellon University (CMU) to develop a new heart monitoring device designed to serve ... , The AGH/CMU team was recently awarded a “Trailblazer” grant from the National ...
(Date:8/31/2020)... ... ... your dear friend has cancer? , It’s hard to hear your doctor say the words ... the shock wears off, the questions and fears can be overwhelming. , How should I ... Words are failing me. I’m scared. I want to DO something. , We’ve talked to ...
(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... Want to ... 1, Cerebral Palsy Alliance Research Foundation (CPARF) is thrilled to launch its fourth annual ... research. A fully virtual challenge, STEPtember meets everyone wherever they are at this moment ...
(Date:8/31/2020)... ... August 31, 2020 , ... Colorado State ... high-quality, career-relevant, and affordable online education – is proud to announce its new ... the first of its kind in the nation, the 60-credit hour program is ...
(Date:8/31/2020)... ... ... and topsy-turvy economic outlook continues to put financial strain on many of us, so it ... from our monthly expenses and put more into savings, if possible. , “That’s a great ... safety net in place in case something were to happen to you,” says Lee Duncan, ...
Breaking Medicine News(10 mins):
(Date:9/1/2020)... ... 2020 , ... Mara C. Weinstein Velez, M.D., FAAD is ... of Rochester Medical Center, in Upstate New York. She completed a prestigious Laser, ... from the Harvard and Yale Departments of Dermatology and is one of the ...
(Date:9/1/2020)... , ... September 01, 2020 , ... September is National ... accounting for more deaths than any other cancer of the female reproductive system. ... with ovarian cancer and about 14,000 women will die from this disease. Throughout ...
(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... ... research and advisory guide, has named Cloudticity a Gold winner in the 15th ... industry and peer recogniti o ns from Network Products Guide honoring ...
Breaking Medicine Technology: